Pharmacological Inhibition of Spermine Oxidase Reduces Neurodegeneration and Improves Retinal Function in Diabetic Mice

Overview

Journal J Clin Med

Specialty General Medicine

Date 2020 Jan 30

PMID 31991839

Citations 24

Authors

Fang Liu

Alan B Saul

Prahalathan Pichavaram

Zhimin Xu

Madhuri Rudraraju

Payaningal R Somanath

Sylvia B Smith

Ruth B Caldwell

S Priya Narayanan

Affiliations

Soon will be listed here.

Abstract

Diabetic retinopathy (DR) is a significant cause of blindness in working-age adults worldwide. Lack of effective strategies to prevent or reduce vision loss is a major problem. Since the degeneration of retinal neurons is an early event in the diabetic retina, studies to characterize the molecular mechanisms of diabetes-induced retinal neuronal damage and dysfunction are of high significance. We have demonstrated that spermine oxidase (SMOX), a mediator of polyamine oxidation is critically involved in causing neurovascular damage in the retina. The involvement of SMOX in diabetes-induced retinal neuronal damage is completely unknown. Utilizing the streptozotocin-induced mouse model of diabetes, the impact of the SMOX inhibitor, MDL 72527, on neuronal damage and dysfunction in the diabetic retina was investigated. Retinal function was assessed by electroretinography (ERG) and retinal architecture was evaluated using spectral domain-optical coherence tomography. Retinal cryosections were prepared for immunolabeling of inner retinal neurons and retinal lysates were used for Western blotting. We observed a marked decrease in retinal function in diabetic mice compared to the non-diabetic controls. Treatment with MDL 72527 significantly improved the ERG responses in diabetic retinas. Diabetes-induced retinal thinning was also inhibited by the MDL 72527 treatment. Our analysis further showed that diabetes-induced retinal ganglion cell damage and neurodegeneration were markedly attenuated by MDL 72527 treatment. These results strongly implicate SMOX in diabetes-induced retinal neurodegeneration and visual dysfunction.

Citing Articles

Targeting SMOX Preserves Optic Nerve Myelin, Axonal Integrity, and Visual Function in Multiple Sclerosis.

Henry-Ojo H, Liu F, Narayanan S Biomolecules. 2025; 15(2).

PMID: 40001462 PMC: 11853291. DOI: 10.3390/biom15020158.

SMOX Inhibition Preserved Visual Acuity, Contrast Sensitivity, and Retinal Function and Reduced Neuro-Glial Injury in Mice During Prolonged Diabetes.

Alfarhan M, Liu F, Matani B, Somanath P, Narayanan S Cells. 2025; 13(24).

PMID: 39768141 PMC: 11674681. DOI: 10.3390/cells13242049.

Regulatory T cell expansion prevents retinal degeneration in type 2 diabetes.

Llorian-Salvador M, Perez-Martinez D, Tang M, Duarri A, Garcia-Ramirez M, Deas-Just A J Neuroinflammation. 2024; 21(1):328.

PMID: 39716335 PMC: 11668053. DOI: 10.1186/s12974-024-03323-0.

Pharmacological Modulation of β-Catenin Preserves Endothelial Barrier Integrity and Mitigates Retinal Vascular Permeability and Inflammation.

Rudraraju M, Shan S, Liu F, Tyler J, Caldwell R, Somanath P J Clin Med. 2023; 12(22).

PMID: 38002758 PMC: 10672253. DOI: 10.3390/jcm12227145.

Urinary acrolein protein conjugates-to-creatinine ratio is positively associated with diabetic peripheral neuropathy in patients with type 2 diabetes mellitus.

Wu T, Su G, Liu T, Wang H, Hwu C Endocr Connect. 2023; 12(11).

PMID: 37698127 PMC: 10563594. DOI: 10.1530/EC-23-0253.

References

Nicoletti R, Venza I, Ceci G, Visalli M, Teti D, Reibaldi A . Vitreous polyamines spermidine, putrescine, and spermine in human proliferative disorders of the retina. Br J Ophthalmol. 2003; 87(8):1038-42. PMC: 1771802. DOI: 10.1136/bjo.87.8.1038. View

Lieth E, Gardner T, Barber A, Antonetti D . Retinal neurodegeneration: early pathology in diabetes. Clin Exp Ophthalmol. 2001; 28(1):3-8. DOI: 10.1046/j.1442-9071.2000.00222.x. View

Yau J, Rogers S, Kawasaki R, Lamoureux E, Kowalski J, Bek T . Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012; 35(3):556-64. PMC: 3322721. DOI: 10.2337/dc11-1909. View

Cervelli M, Amendola R, Polticelli F, Mariottini P . Spermine oxidase: ten years after. Amino Acids. 2011; 42(2-3):441-50. DOI: 10.1007/s00726-011-1014-z. View

Yong P, Zong H, Medina R, Limb G, Uchida K, Stitt A . Evidence supporting a role for N-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy. Mol Vis. 2010; 16:2524-38. PMC: 3000235. View

Zhang X, Lai Y, McCance D, Uchida K, McDonald D, Gardiner T . Evaluation of N (epsilon)-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy. Diabetologia. 2008; 51(9):1723-30. DOI: 10.1007/s00125-008-1071-3. View

Krady J, Basu A, Allen C, Xu Y, LaNoue K, Gardner T . Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes. 2005; 54(5):1559-65. DOI: 10.2337/diabetes.54.5.1559. View

Cervelli M, Polticelli F, Fiorucci L, Angelucci E, Federico R, Mariottini P . Inhibition of acetylpolyamine and spermine oxidases by the polyamine analogue chlorhexidine. J Enzyme Inhib Med Chem. 2012; 28(3):463-7. DOI: 10.3109/14756366.2011.650691. View

Caldwell R, Bartoli M, Behzadian M, El-Remessy A, Al-Shabrawey M, Platt D . Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev. 2003; 19(6):442-55. DOI: 10.1002/dmrr.415. View

10.

Saszik S, Robson J, Frishman L . The scotopic threshold response of the dark-adapted electroretinogram of the mouse. J Physiol. 2002; 543(Pt 3):899-916. PMC: 2290546. DOI: 10.1113/jphysiol.2002.019703. View

11.

Capone C, Cervelli M, Angelucci E, Colasanti M, Macone A, Mariottini P . A role for spermine oxidase as a mediator of reactive oxygen species production in HIV-Tat-induced neuronal toxicity. Free Radic Biol Med. 2013; 63:99-107. DOI: 10.1016/j.freeradbiomed.2013.05.007. View

12.

DAmico A, Maugeri G, Bucolo C, Saccone S, Federico C, Cavallaro S . Nap Interferes with Hypoxia-Inducible Factors and VEGF Expression in Retina of Diabetic Rats. J Mol Neurosci. 2016; 61(2):256-266. DOI: 10.1007/s12031-016-0869-6. View

13.

Jackson G, Scott I, Quillen D, Walter L, Gardner T . Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy. Br J Ophthalmol. 2011; 96(5):699-703. DOI: 10.1136/bjophthalmol-2011-300467. View

14.

Abu El-Asrar A, Dralands L, Missotten L, Geboes K . Expression of antiapoptotic and proapoptotic molecules in diabetic retinas. Eye (Lond). 2006; 21(2):238-45. DOI: 10.1038/sj.eye.6702225. View

15.

Ivanova S, Batliwalla F, Mocco J, Kiss S, Huang J, Mack W . Neuroprotection in cerebral ischemia by neutralization of 3-aminopropanal. Proc Natl Acad Sci U S A. 2002; 99(8):5579-84. PMC: 122812. DOI: 10.1073/pnas.082609299. View

16.

Seghieri G, Gironi A, Niccolai M, MAMMINI P, Alviggi L, De Giorgio L . Serum spermidine oxidase activity in patients with insulin-dependent diabetes mellitus and microvascular complications. Acta Diabetol Lat. 1990; 27(4):303-8. DOI: 10.1007/BF02580934. View

17.

Seiler N . Oxidation of polyamines and brain injury. Neurochem Res. 2000; 25(4):471-90. DOI: 10.1023/a:1007508008731. View

18.

Oshitari T, Yamamoto S, Hata N, Roy S . Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy. Br J Ophthalmol. 2008; 92(4):552-6. DOI: 10.1136/bjo.2007.132308. View

19.

Takano K, Ogura M, Nakamura Y, Yoneda Y . Neuronal and glial responses to polyamines in the ischemic brain. Curr Neurovasc Res. 2005; 2(3):213-23. DOI: 10.2174/1567202054368335. View

20.

Mesquida M, Drawnel F, Fauser S . The role of inflammation in diabetic eye disease. Semin Immunopathol. 2019; 41(4):427-445. DOI: 10.1007/s00281-019-00750-7. View